ArticleInfection & chemotherapy2026
Incidence and Risk Factors for Recurrence of NDM- and KPC-Producing Enterobacterales after Achieving Clearance: A Retrospective Study.
Article in Infection & chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe aimed to determine the incidence and risk factors of recurrence after clearance of carbapenemase-producing Enterobacterales (CPE). We also sought to investigate whether there were differences in recurrence according to carbapenemase type. MATERIALS AND
methodsWe conducted a retrospective case-control study (From January 2022 to December 2023) at a tertiary referral hospital in Korea. Recurrence was defined as positive culture or PCR test results for CPE with the same genotype as the first CPE isolation within 1 year after clearance.
resultsAmong 1,503 patients with New Delhi metallo-β-lactamase (NDM)- or
conclusionRecurrence occurred in approximately one out of ten patients after clearance within one year, and did not differ significantly by carbapenemase type. Post-clearance indwelling devices, particularly central venous catheters, were associated with recurrence, underscoring the need for targeted infection control strategies after documented clearance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.